THE RELATIONSHIP OF TNFα -308 G/A POLYMORPHISM WITH THE INCIDENCE OF CERVICAL CANCER IN ASIAN WOMEN: A META ANALYSIS OBSERVATIONAL STUDY
Main Article Content
Abstract
Cervical cancer is a malignancy with high mortality rates in women, and its incidence continues to rise. The main etiological factor for cervical cancer is infection with Human Papillomavirus (HPV), which disrupts the regulation of apoptosis in cells. Several studies have shown a correlation between TNFα polymorphisms, including the -308 position (TNFα -308 G/A), and the incidence of cervical cancer.This gene have a role in proliferation of cancer cells. This study investigates the impact of TNFα-308 polymorphism on the risk of cervical cancer in Asian female populations. A meta-analysis of five sources was conducted to determine potential associations. Findings reveal that neither allele A (OR 95%CI = 1.20 [0.70-2.03], p = 0.51) nor genotype AA (OR 95%CI = 0.85 [0.37-1.91], p = 0.69) were significantly linked with an elevated risk of cervical cancer in Asian women. The same result was seen for the G allele (OR 95%CI = 0.84 [0.49-1.42], p = 0.51) and GG genotype (OR 95%CI = 0.80 [0.44-1.48], p = 0.48). The study results indicate that the TNFα-308 polymorphism is not associated with cervical cancer in Asian women. Further research is needed to investigate the role of other gene polymorphisms in cervical cancer susceptibility in Asian women.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
a). Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial-ShareAlike 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b). Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
Du G, Wang J, Richards JR, Wang J, Province S, City SL, Provincial S, Province S (2019) Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer. Int Immunopharmacol 66:154–161. https://doi.org/10.1016/j.intimp.2018.11.015.Genetic
GLOBOCAN (2020) Estimated age-standardized incidence rates (World) in 2020, World, females, all ages (excl. NMSC). Int Agency Reasearch Cancer, World Heal Organ 2020
Kesehatan K (2021) Profil Data Kesehatan Indonesia 2021
Li L, Liu J, Liu C, Lu X (2018a) The correlation between tnf-α-308 gene polymorphism and susceptibility to cervical cancer. Oncol Lett 15:7163–7167. https://doi.org/10.3892/ol.2018.8246
Li X, Yin G, Li J, Wu A, Yuan Z, Liang J, Sun Q (2018b) The correlation between TNF-α promoter gene polymorphism and genetic susceptibility to cervical cancer. Technol Cancer Res Treat 17:1–7. https://doi.org/10.1177/1533033818782793
Momenimovahed Z, Mazidimoradi A, Amiri S, Nooraie Z, Allahgholi L, Salehiniya H (2023) Temporal trends of cervical cancer between 1990 and 2019, in Asian countries by geographical region and socio-demographic index, and comparison with global data. Oncologie 25:119–148. https://doi.org/10.1515/oncologie-2022-1009
Salehaniya H, Momenimovahed Z, Allahqoli L, Momenimovahed S, Alkatout I (2021) Factors related to cervical cancer screening among Asian women. Eur Rev Med Pharmacol Sci 25:6109–6122. https://doi.org/10.26355/eurrev_202110_26889
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F, Vaccarella S (2023) Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Heal 11:e197–e206. https://doi.org/10.1016/S2214-109X(22)00501-0
Thakre TR, Singh A, Mitra M (2019) Association gene polymorphism and cervical cancer among women of Chhattisgarh. J Pharm Technol 12:2339–2342. https://doi.org/10.5958/0974-360X.2019.00389.5
Traore IMA, Zohoncon TM, Djigma FW, Compaore TR, Traore Y, Simpore J (2020) Association of TNF-α-308G/A and IL-18 Polymorphisms with risk of HPV infection among sexually active women in Burkina Faso. Biomol Concepts 11:97–101. https://doi.org/10.1515/bmc-2020-0008
Yang J, Wang Y, Zhang S, Li Y, Li C, Liu W, Liu S, Liang Y, Zhang X, Yan Z, Shi L, Yao Y (2022) The Association of TNF-α Promoter Polymorphisms with Genetic Susceptibility to Cervical Cancer in a Chinese Han Population. Int J Gen Med 15:417–427. https://doi.org/10.2147/IJGM.S350263
Zhao M, Wu Q, Hao Y, Hu J, Gao Y, Zhou S, Han L (2021) Global, regional, and national burden of cervical cancer for 195 countries and territories, 2007–2017: findings from the Global Burden of Disease Study 2017. BMC Womens Health 21:1–13. https://doi.org/10.1186/s12905-021-01571-3
Zuo F, Liang W, Ouyang Y, Li W, Lv M, Wang G, Ding M, Wang B, Zhao S, Liu J, Jiang Z, Li M (2011) Association of TNF-α gene promoter polymorphisms with susceptibility of cervical cancer in southwest china. Lab Med 42:287–290. https://doi.org/10.1309/LM532DSPDUXIRJVN